Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03451409 · ClinicalTrials.gov registry record
Neurobiology of Sensory Phenomena in Obsessive-Compulsive Disorder
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 308
- Enrollment target
NCT03451409 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 308 participants.
The verdict
NCT03451409 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 308 participants
- Enrollment target
Study Summary
The Research Domain Criteria (RDoC) approach seeks to address the neurobiological mechanisms of sensory symptoms in patients with obsessive-compulsive disorder (OCD) by investigating dimensional components of behavior that more closely align with brain circuitry. This project focuses on the dimensional symptom of sensory phenomena (SP), which are uncomfortable or aversive sensory experiences that drive repetitive behaviors in OCD, including "not just right" sensations, physical urges, and sensations of disgust. SP are very prevalent, occurring in 60-80% of OCD patients, and experienced as highly distressing. Unfortunately, SP are not well addressed by standard treatment approaches, which may be in part because their neurobiological mechanisms are not well understood. This project builds on our preliminary data to (1) investigate the neural mechanisms of SP in large OCD cohort showing the full range of SP severity and (2) probe for familial risk markers in unaffected siblings of patients. For Aim 1, SP will be measured in 100 OCD patients using the Sensory Phenomena Scale. Diffusion and fMRI data will be acquired during rest and fMRI tasks. In order to identify familial risk markers, Aim 2 will compare sensory phenomena and neural circuitry between OCD probands, 50 unaffected biological siblings of OCD patients, and 50 unrelated healthy controls without a family history of Axis 1 disorders.
Interventions
- OTHER Tasked based functional MRI (fMRI)
- OTHER Eye Tracking Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 308 participants |
| Start Date | 2018-05-05 |
| Est. Completion | 2024-01-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03451409
The ClinicalTrials.gov registry entry for NCT03451409 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 308 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tasked based functional MRI (fMRI) is the first listed.
NCT03451409 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03451409 about?
NCT03451409 is a clinical study titled "Neurobiology of Sensory Phenomena in Obsessive-Compulsive Disorder". The Research Domain Criteria (RDoC) approach seeks to address the neurobiological mechanisms of sensory symptoms in patients with obsessive-compulsive disorder (OCD) by investigating dimensional components of behavior that more closely align with brain circuitry. This project focuses on the dimensio...
What is the current status of trial NCT03451409?
This trial is currently completed. The enrollment target is 308 participants. The study started on 2018-05-05. Estimated completion is 2024-01-24.
What interventions are being tested in trial NCT03451409?
The interventions under investigation include: Tasked based functional MRI (fMRI) (OTHER), Eye Tracking Device (OTHER).
Who is sponsoring clinical trial NCT03451409?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.